These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18267354)

  • 1. Does minocycline have antidepressant effect?
    Pae CU; Marks DM; Han C; Patkar AA
    Biomed Pharmacother; 2008 Jun; 62(5):308-11. PubMed ID: 18267354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does neurotropin-3 have a therapeutic implication in major depression?
    Pae CU; Marks DM; Han C; Patkar AA; Steffens D
    Int J Neurosci; 2008 Nov; 118(11):1515-22. PubMed ID: 18853330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antidepressant-like actions of minocycline combined with several glutamate antagonists.
    Molina-Hernández M; Tellez-Alcántara NP; Pérez-García J; Olivera-Lopez JI; Jaramillo-Jaimes MT
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):380-6. PubMed ID: 17933448
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glatiramer acetate could be a potential antidepressant through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(1):145-8. PubMed ID: 17196755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Desipramine or glutamate antagonists synergized the antidepressant-like actions of intra-nucleus accumbens infusions of minocycline in male Wistar rats.
    Molina-Hernández M; Téllez-Alcántara NP; Pérez-García J; Olivera-Lopez JI; Jaramillo-Jaimes MT
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Oct; 32(7):1660-6. PubMed ID: 18640173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sipatrigine could have therapeutic potential for major depression and bipolar depression through antagonism of the two-pore-domain K+ channel TREK-1.
    Tsai SJ
    Med Hypotheses; 2008; 70(3):548-50. PubMed ID: 17703894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic implication of cocaine- and amphetamine-regulated transcript (CART) in the treatment of depression.
    Pae CU; Lee C; Paik IH
    Med Hypotheses; 2007; 69(1):132-5. PubMed ID: 17196760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. sigma-1 receptors in major depression and anxiety.
    Kulkarni SK; Dhir A
    Expert Rev Neurother; 2009 Jul; 9(7):1021-34. PubMed ID: 19589051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of CREB in depression and antidepressant treatment.
    Blendy JA
    Biol Psychiatry; 2006 Jun; 59(12):1144-50. PubMed ID: 16457782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What should animal models of depression model?
    Frazer A; Morilak DA
    Neurosci Biobehav Rev; 2005; 29(4-5):515-23. PubMed ID: 15893377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minocycline: a neuroprotective agent for hypoxic-ischemic brain injury in the neonate?
    Buller KM; Carty ML; Reinebrant HE; Wixey JA
    J Neurosci Res; 2009 Feb; 87(3):599-608. PubMed ID: 18831005
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cysteamine-related agents could be potential antidepressants through increasing central BDNF levels.
    Tsai SJ
    Med Hypotheses; 2006; 67(5):1185-8. PubMed ID: 16797865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior.
    Schmidt HD; Duman RS
    Behav Pharmacol; 2007 Sep; 18(5-6):391-418. PubMed ID: 17762509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deltamethrin, a pyrethroid insecticide, could be a potential antidepressant agent.
    Tsai SJ
    Med Hypotheses; 2006; 66(3):605-8. PubMed ID: 16310970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
    Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
    Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.
    Henkel V; Seemüller F; Obermeier M; Adli M; Bauer M; Mundt C; Brieger P; Laux G; Bender W; Heuser I; Zeiler J; Gaebel W; Mayr A; Möller HJ; Riedel M
    J Affect Disord; 2009 Jun; 115(3):439-49. PubMed ID: 19027961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing activity onset time and efficacy for clinically effective antidepressant and antimanic drugs in animal models based on dominant-submissive relationships.
    Malatynska E; Pinhasov A; Creighton CJ; Crooke JJ; Reitz AB; Brenneman DE; Lubomirski MS
    Neurosci Biobehav Rev; 2007; 31(6):904-19. PubMed ID: 17597209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiapoptotic and neurotrophic effects of antidepressants: a review of clinical and experimental studies.
    Drzyzga ŁR; Marcinowska A; Obuchowicz E
    Brain Res Bull; 2009 Jun; 79(5):248-57. PubMed ID: 19480984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rise and fall of minocycline in neuroprotection: need to promote publication of negative results.
    Diguet E; Gross CE; Tison F; Bezard E
    Exp Neurol; 2004 Sep; 189(1):1-4. PubMed ID: 15296829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.